These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 34100973)

  • 1. Safety and efficacy of polydimethylsiloxane (Macroplastique®) in women with stress urinary incontinence: analysis of data from patients who completed three years follow-up.
    Ghoniem G; Farhan B; Chowdhury ML; Chen Y
    Int Urogynecol J; 2021 Oct; 32(10):2835-2840. PubMed ID: 34100973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term Outcomes With Macroplastique in Women With Stress Urinary Incontinence Secondary to Intrinsic Sphincter Deficiency.
    Kusin SB; Carroll TF; Alhalabi F; Christie AL; Zimmern PE
    Urology; 2024 Mar; 185():36-43. PubMed ID: 38199277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of Macroplastique injections for stress urinary incontinence after suburethral sling removal.
    Rodríguez D; Carroll T; Alhalabi F; Carmel M; Zimmern PE
    Neurourol Urodyn; 2020 Mar; 39(3):994-1001. PubMed ID: 32068306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does the Polydimethylsiloxane Urethral Injection (Macroplastique
    Serati M; Braga A; Scancarello C; De Rosa A; Frigerio M; Baruch Y; Torella M; Salvatore S; Ruffolo AF
    Medicina (Kaunas); 2023 Mar; 59(3):. PubMed ID: 36984580
    [No Abstract]   [Full Text] [Related]  

  • 5. Macroplastique for women with stress urinary incontinence secondary to intrinsic sphincter deficiency.
    Carroll TF; Christie A; Foreman M; Khatri G; Zimmern PE
    Int Braz J Urol; 2019; 45(5):989-998. PubMed ID: 31626522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of polydimethylsiloxane injection (Macroplastique
    Serati M; Soligo M; Braga A; Cantaluppi S; Coluccia AC; Di Dedda MC; Salvatore S; Cetin I; Ghezzi F;
    BJU Int; 2019 Feb; 123(2):353-359. PubMed ID: 30253026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Durability of Macroplastique volume and configuration in women with stress urinary incontinence secondary to intrinsic sphincter deficiency: A retrospective review.
    Carroll TF; Christie A; Foreman M; Kuprasertkul A; Khatri G; Zimmern PE
    Low Urin Tract Symptoms; 2021 Jul; 13(3):335-340. PubMed ID: 33354906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-linked polydimethylsiloxane injection for female stress urinary incontinence: results of a multicenter, randomized, controlled, single-blind study.
    Ghoniem G; Corcos J; Comiter C; Bernhard P; Westney OL; Herschorn S
    J Urol; 2009 Jan; 181(1):204-10. PubMed ID: 19013613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bladder neck and urethral erosions after Macroplastique injections.
    Rodríguez D; Jaffer A; Hilmy M; Zimmern P
    Low Urin Tract Symptoms; 2021 Jan; 13(1):93-97. PubMed ID: 32783393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between porcine dermal implant (Permacol) and silicone injection (Macroplastique) for urodynamic stress incontinence.
    Bano F; Barrington JW; Dyer R
    Int Urogynecol J Pelvic Floor Dysfunct; 2005; 16(2):147-50; discussion 150. PubMed ID: 15378234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Durability of urethral bulking agent injection for female stress urinary incontinence: 2-year multicenter study results.
    Ghoniem G; Corcos J; Comiter C; Westney OL; Herschorn S
    J Urol; 2010 Apr; 183(4):1444-9. PubMed ID: 20171691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Macroplastique Implantation System for stress urinary incontinence and urethral hypermobility in women.
    ter Meulen PH; Berghmans LC; Nieman FH; van Kerrebroeck PE
    Int Urogynecol J Pelvic Floor Dysfunct; 2009 Feb; 20(2):177-83. PubMed ID: 18936867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pubovaginal sling versus transurethral Macroplastique for stress urinary incontinence and intrinsic sphincter deficiency: a prospective randomised controlled trial.
    Maher CF; O'Reilly BA; Dwyer PL; Carey MP; Cornish A; Schluter P
    BJOG; 2005 Jun; 112(6):797-801. PubMed ID: 15924540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the Macroplastique Implantation System for stress urinary incontinence in women with or without a history of an anti-incontinence operation.
    Gumus II; Kaygusuz I; Derbent A; Simavli S; Kafali H
    Int Urogynecol J; 2011 Jun; 22(6):743-9. PubMed ID: 21461709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transurethral implantation of macroplastique for the treatment of female stress urinary incontinence secondary to urethral sphincter deficiency.
    Radley SC; Chapple CR; Mitsogiannis IC; Glass KS
    Eur Urol; 2001 Apr; 39(4):383-9. PubMed ID: 11306875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macroplastique implantation system for the treatment of female stress urinary incontinence.
    Tamanini JT; D'Ancona CA; Tadini V; Netto NR
    J Urol; 2003 Jun; 169(6):2229-33. PubMed ID: 12771756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical presentation and treatment of Macroplastique® urethral exposures: a retrospective case series.
    Ramirez-Caban L; Malekzadeh M; Ossin DA; Hurtado EA
    Int Urogynecol J; 2022 Mar; 33(3):681-687. PubMed ID: 34213601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macroplastique Is a Safe and Effective Long-term Surgical Treatment for Stress Urinary Incontinence: Prospective Study with 10-Year Follow-up.
    Serati M; Scancarello C; Mesiano G; Cimmino C; Campitiello MR; Salvatore S; Ghezzi F; Caccia G; Papadia A; Braga A
    Eur Urol Focus; 2024 Aug; ():. PubMed ID: 39095217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic review and meta-analysis of Macroplastique for treating female stress urinary incontinence.
    Ghoniem GM; Miller CJ
    Int Urogynecol J; 2013 Jan; 24(1):27-36. PubMed ID: 22699885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of intrinsic sphincter deficiency using the Macroplastique Implantation System: two-year follow-up.
    Tamanini JT; D'Ancona CA; Netto NR
    J Endourol; 2004 Nov; 18(9):906-11. PubMed ID: 15659931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.